
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $29K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $15K | |
Gross Profit | -- | -- | -- | -- | $14K | |
Gross Profit Margin | -- | -- | -- | -- | 48.28% | |
R&D Expenses | -- | $81K | $129K | $124K | $339K | |
Selling, General & Admin | -- | $637K | $2M | $1.5M | $1.5M | |
Other Inc / (Exp) | -- | -$2.5M | $910K | $262K | -$2M | |
Operating Expenses | -- | $718K | $2.2M | $1.6M | $1.8M | |
Operating Income | -- | -$718K | -$2.2M | -$1.6M | -$1.8M | |
Net Interest Expenses | -- | $6K | $52K | $441K | $171K | |
EBT. Incl. Unusual Items | -- | -$3.2M | -$1.3M | -$1.8M | -$4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$3.2M | -$1.3M | -$1.8M | -$4M | |
Minority Interest in Earnings | -- | $2K | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$3.2M | -$1.3M | -$1.8M | -$4M | |
Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.01 | -$0.01 | -$0.01 | |
Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.01 | -$0.01 | -$0.01 | |
Weighted Average Basic Share | -- | $118.9M | $219.6M | $257.2M | $456.1M | |
Weighted Average Diluted Share | -- | $118.9M | $219.6M | $257.2M | $456.1M | |
EBITDA | -- | -$3.2M | -$1.2M | -$1.4M | -$3.8M | |
EBIT | -- | -$3.2M | -$1.3M | -$1.4M | -$3.9M | |
Revenue (Reported) | -- | -- | -- | -- | $29K | |
Operating Income (Reported) | -- | -$718K | -$2.2M | -$1.6M | -$1.8M | |
Operating Income (Adjusted) | -- | -$3.2M | -$1.3M | -$1.4M | -$3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $13K | $3K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -76.92% | |
Cost of Revenues | -- | -- | -- | $3K | $4K | |
Gross Profit | -- | -- | -- | $10K | -$1K | |
Gross Profit Margin | -- | -- | -- | 76.92% | -33.33% | |
R&D Expenses | -- | $25K | $9K | $60K | -$6K | |
Selling, General & Admin | -- | $455K | $427K | $348K | $128K | |
Other Inc / (Exp) | -- | $1.2M | $166K | -$824K | -$44K | |
Operating Expenses | -- | $480K | $436K | $408K | $122K | |
Operating Income | -- | -$480K | -$436K | -$398K | -$123K | |
Net Interest Expenses | -- | $16K | $19K | $22K | -- | |
EBT. Incl. Unusual Items | -- | $752K | -$289K | -$1.2M | -$166K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | $752K | -$289K | -$1.2M | -$166K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $752K | -$289K | -$1.2M | -$166K | |
Basic EPS (Cont. Ops) | -- | $0.00 | -$0.00 | -$0.00 | -$0.00 | |
Diluted EPS (Cont. Ops) | -- | $0.00 | -$0.00 | -$0.00 | -$0.00 | |
Weighted Average Basic Share | -- | $218.2M | $225.2M | $380.3M | $527.9M | |
Weighted Average Diluted Share | -- | $691.8M | $225.2M | $380.3M | $527.9M | |
EBITDA | -- | $774K | -$430K | -$392K | -$117K | |
EBIT | -- | $768K | -$436K | -$398K | -$123K | |
Revenue (Reported) | -- | -- | -- | $13K | $3K | |
Operating Income (Reported) | -- | -$480K | -$436K | -$398K | -$123K | |
Operating Income (Adjusted) | -- | $768K | -$436K | -$398K | -$123K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $19K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $16K | |
Gross Profit | -- | -- | -- | $10K | $3K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $113K | $175K | $272K | |
Selling, General & Admin | -- | $1.1M | $2M | $1.4M | $1.3M | |
Other Inc / (Exp) | -- | $1.1M | -$172K | -$728K | -$1.3M | |
Operating Expenses | -- | $1.2M | $2.1M | $1.6M | $1.6M | |
Operating Income | -- | -$1.2M | -$2.1M | -$1.6M | -$1.5M | |
Net Interest Expenses | -- | $58.1K | $55K | $444K | $150K | |
EBT. Incl. Unusual Items | -- | -$2.6M | -$2.3M | -$2.8M | -$3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -$2.3M | -$2.8M | -$3M | |
Minority Interest in Earnings | -- | $2K | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$2.6M | -$2.3M | -$2.8M | -$3M | |
Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.01 | -$0.01 | -$0.01 | |
Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.01 | -$0.01 | -$0.01 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$2.5M | -$1.2M | -$1.6M | -$3.5M | |
EBIT | -- | -$2.5M | -$1.2M | -$1.6M | -$3.5M | |
Revenue (Reported) | -- | -- | -- | -- | $19K | |
Operating Income (Reported) | -- | -$1.2M | -$2.1M | -$1.6M | -$1.5M | |
Operating Income (Adjusted) | -- | -$2.5M | -$1.2M | -$1.6M | -$3.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $13K | $3K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $3K | $4K | |
Gross Profit | -- | -- | -- | $10K | -$1K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $25K | $9K | $60K | -$6K | |
Selling, General & Admin | -- | $455K | $427K | $348K | $128K | |
Other Inc / (Exp) | -- | $1.2M | $166K | -$824K | -$44K | |
Operating Expenses | -- | $480K | $436K | $408K | $122K | |
Operating Income | -- | -$480K | -$436K | -$398K | -$123K | |
Net Interest Expenses | -- | $16K | $19K | $22K | -- | |
EBT. Incl. Unusual Items | -- | $752K | -$289K | -$1.2M | -$166K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | $752K | -$289K | -$1.2M | -$166K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $752K | -$289K | -$1.2M | -$166K | |
Basic EPS (Cont. Ops) | -- | $0.00 | -$0.00 | -$0.00 | -$0.00 | |
Diluted EPS (Cont. Ops) | -- | $0.00 | -$0.00 | -$0.00 | -$0.00 | |
Weighted Average Basic Share | -- | $218.2M | $225.2M | $380.3M | $527.9M | |
Weighted Average Diluted Share | -- | $691.8M | $225.2M | $380.3M | $527.9M | |
EBITDA | -- | $774K | -$430K | -$392K | -$117K | |
EBIT | -- | $768K | -$436K | -$398K | -$123K | |
Revenue (Reported) | -- | -- | -- | $13K | $3K | |
Operating Income (Reported) | -- | -$480K | -$436K | -$398K | -$123K | |
Operating Income (Adjusted) | -- | $768K | -$436K | -$398K | -$123K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $206K | $60K | $222K | $79K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | $14K | $23K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $356K | $79K | $278K | $131K | |
Property Plant And Equipment | -- | $2K | $2K | $3K | $3K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $506K | $205K | $474K | $385K | |
Accounts Payable | -- | $30K | $67K | $51K | $33K | |
Accrued Expenses | -- | $13K | $62K | $109K | $41K | |
Current Portion Of Long-Term Debt | -- | $2.2M | $2.3M | $2.1M | $1.4M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $260K | $24K | $204K | -- | |
Total Current Liabilities | -- | $2.5M | $2.8M | $3M | $1.7M | |
Long-Term Debt | -- | $415K | -- | -- | $2.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $2.9M | $2.8M | $3M | $4.5M | |
Common Stock | -- | $21K | $21K | $31K | $50K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -$2.4M | -$2.5M | -$2.5M | -$4.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -$14K | -$14K | -$14K | -$14K | |
Total Equity | -- | -$2.4M | -$2.6M | -$2.6M | -$4.1M | |
Total Liabilities and Equity | -- | $506K | $205K | $474K | $385K | |
Cash and Short Terms | -- | $206K | $60K | $222K | $79K | |
Total Debt | -- | $2.6M | $2.3M | $2.1M | $4.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $100K | $373K | $95K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | $1K | -- | |
Inventory | -- | -- | -- | $14K | $47K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $118K | $418K | $162K | |
Property Plant And Equipment | -- | -- | $1K | $2K | $3K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | $237K | $658K | $411K | |
Accounts Payable | -- | -- | $38K | $24K | $40K | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | $2.2M | $3.1M | $1.4M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $14K | $72K | -- | |
Total Current Liabilities | -- | -- | $2.6M | $3.8M | $1.7M | |
Long-Term Debt | -- | -- | -- | -- | $2.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $2.6M | $3.8M | $4.6M | |
Common Stock | -- | -- | $22K | $41K | $52K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -$14K | -$14K | -$14K | |
Total Equity | -- | -- | -$2.4M | -$3.2M | -$4.2M | |
Total Liabilities and Equity | -- | -- | $237K | $658K | $411K | |
Cash and Short Terms | -- | -- | $100K | $373K | $95K | |
Total Debt | -- | -- | $2.2M | $3.1M | $4.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$3.2M | -$1.3M | -$1.8M | -$4M | |
Depreciation & Amoritzation | -- | $16K | $24K | $25K | $24K | |
Stock-Based Compensation | -- | $485K | $1.1M | $796K | $1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -$14K | -$10K | |
Cash From Operations | -- | -$168K | -$595K | -$597K | -$785K | |
Capital Expenditures | -- | $3K | -- | $93K | $80K | |
Cash Acquisitions | -- | $170K | -- | -- | -- | |
Cash From Investing | -- | $167K | -- | -$93K | -$80K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $60K | $472K | $141K | $2K | |
Long-Term Debt Repaid | -- | -- | -$30K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $724K | -- | |
Cash From Financing | -- | $196K | $442K | $865K | $719K | |
Beginning Cash (CF) | -- | $11K | $206K | $60K | $222K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $195K | -$153K | $175K | -$146K | |
Ending Cash (CF) | -- | $206K | $60K | $222K | $79K | |
Levered Free Cash Flow | -- | -$171K | -$595K | -$690K | -$865K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $752K | -$289K | -$1.2M | -$166K | |
Depreciation & Amoritzation | -- | $6K | $6K | $6K | $6K | |
Stock-Based Compensation | -- | $252K | $279K | $172K | -$10K | |
Change in Accounts Receivable | -- | -- | -- | $11K | $9K | |
Change in Inventories | -- | -- | -- | -$1K | -$23K | |
Cash From Operations | -- | -$127K | -$97K | -$257K | -$103K | |
Capital Expenditures | -- | -- | -- | $50K | $1K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$50K | -$1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $141K | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $75K | $124K | |
Cash From Financing | -- | -- | $141K | $456K | $124K | |
Beginning Cash (CF) | -- | $206K | $60K | $222K | $79K | |
Foreign Exchange Rate Adjustment | -- | -- | -$4K | $3K | -$5K | |
Additions / Reductions | -- | -$127K | $44K | $148K | $21K | |
Ending Cash (CF) | -- | $79K | $100K | $373K | $95K | |
Levered Free Cash Flow | -- | -$127K | -$97K | -$307K | -$104K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$2.3M | -$2.8M | -$3M | |
Depreciation & Amoritzation | -- | -- | $24K | $25K | $24K | |
Stock-Based Compensation | -- | $252K | $1.2M | $689K | $847K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -$15K | -$32K | |
Cash From Operations | -- | -- | -$565K | -$757K | -$631K | |
Capital Expenditures | -- | -- | -- | $143K | $31K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$143K | -$31K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $613K | -- | $2K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $799K | -- | |
Cash From Financing | -- | -- | $583K | $1.2M | $387K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $18K | $279K | -$273K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$218.5K | -$565K | -$900K | -$662K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $752K | -$289K | -$1.2M | -$166K | |
Depreciation & Amoritzation | -- | $6K | $6K | $6K | $6K | |
Stock-Based Compensation | -- | $252K | $279K | $172K | -$10K | |
Change in Accounts Receivable | -- | -- | -- | $11K | $9K | |
Change in Inventories | -- | -- | -- | -$1K | -$23K | |
Cash From Operations | -- | -$127K | -$97K | -$257K | -$103K | |
Capital Expenditures | -- | -- | -- | $50K | $1K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$50K | -$1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $141K | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $75K | $124K | |
Cash From Financing | -- | -- | $141K | $456K | $124K | |
Beginning Cash (CF) | -- | $206K | $60K | $222K | $79K | |
Foreign Exchange Rate Adjustment | -- | -- | -$4K | $3K | -$5K | |
Additions / Reductions | -- | -$127K | $44K | $148K | $21K | |
Ending Cash (CF) | -- | $79K | $100K | $373K | $95K | |
Levered Free Cash Flow | -- | -$127K | -$97K | -$307K | -$104K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.